An inquest into the death of Sir Richard Branson’s wife, Lady Joan Branson, has concluded that her fatal blood clot may have been prevented if she had received anti-clotting medication earlier during her hospital treatment.

Lady Joan Sarah Drummond Branson, 80, died in November 2025 after developing a major pulmonary embolism — a serious blockage in the lungs caused by a blood clot. The inquest heard that the condition developed following complications from injuries she suffered after a fall at the family’s Necker Island home in the Caribbean.

Senior coroner Professor Fiona Wilcox said the death was likely avoidable and concluded that the absence of anticoagulant treatment contributed to the outcome.

“If this lady had been given anticoagulation early on, her death would, on the balance of probability, have been prevented,” the coroner said during her conclusion.

Fall on Necker Island Led to Hospital Admission

Lady Joan was admitted to The Lister Hospital in Chelsea after experiencing ongoing pain following a fall at the Branson family’s private island residence.

The court heard that she had tripped near her bed and was unable to get up immediately because of the pain.

Doctors later discovered injuries connected to the fall, but concerns about possible internal bleeding affected decisions around medication.

Lady Joan’s medical history was also significant. She had previously suffered from blood clots and had used anti-coagulant injections in the past.

The inquest heard that she had previously taken medication such as Enoxaparin, a drug commonly used to reduce the risk of dangerous blood clots.

Questions Over Missed Anti-Clotting Medication

A central issue during the hearing was why Lady Joan was not given preventative blood-thinning treatment after being admitted.

Medical experts told the inquest that patients with certain risk factors should receive a venous thromboembolism (VTE) assessment and, where appropriate, anticoagulant medication.

The court heard that such an assessment was not completed as expected.

Dr Nevil Pavithran, who later became involved in Lady Joan’s care, said she should have received anti-clotting treatment within hours of arriving at hospital.

Another doctor involved in her care, Dr Inaki Bovill, acknowledged that the medication should have been prescribed and expressed regret that he did not push more strongly for it.

He told the hearing that, looking back, he wished he had been more forceful in ensuring she received the treatment.

Daughter Challenges Claim That Joan Refused Medication

Lady Joan’s daughter, Dr Holly Branson, raised concerns about suggestions that her mother had declined the injections.

Holly, who has a medical background, told the hearing that she did not believe her mother would have refused Enoxaparin.

She explained that Joan was familiar with anti-clotting injections and had previously accepted them during medical treatment and long-haul travel.

Holly said the suggestion that her mother rejected the medication because of discomfort or concerns about bruising did not match her understanding of Joan’s usual approach to healthcare.

She also said she was surprised to discover that her mother had not received the injections after admission.

Doctors Express Regret Over Treatment Decisions

The inquest heard evidence from several medical professionals involved in Lady Joan’s care.

Doctors explained that concerns about possible bleeding after her fall influenced decisions regarding anticoagulant treatment.

Dr Basir Kunduzi said he had delayed prescribing the medication because he wanted further investigation to rule out bleeding risks.

However, he later accepted that Lady Joan should have received the treatment and said the decision would stay with him.

He also acknowledged the importance of clearer communication between medical teams when making complex treatment decisions.

The hearing highlighted how multiple decisions and communication failures contributed to a missed opportunity to prevent the fatal clot.

Richard Branson’s Tribute to His Wife

Sir Richard Branson announced his wife’s death in November 2025, describing himself as devastated by the loss.

The Virgin Group founder paid tribute to Joan as his partner, closest companion and the heart of their family.

The couple had been together for decades after first meeting in the 1970s and marrying on Necker Island in 1989.

During their long relationship, Joan remained a private but influential figure within Branson’s life, supporting him through the growth of the Virgin business empire.

Branson previously described her as an extraordinary mother and grandmother who brought stability and warmth to their family.

A Wider Warning About Blood Clot Prevention

The findings from the inquest have highlighted the importance of recognising blood clot risks in hospital patients, particularly those who have suffered injuries, undergone periods of reduced mobility or have previous clotting problems.

Pulmonary embolisms can develop when clots form in the deep veins, often in the legs, before travelling to the lungs.

Preventative anticoagulant medication is commonly used for patients considered at increased risk, although doctors must balance this against the danger of bleeding.

The case has raised questions about how hospitals assess these risks and how medical teams communicate decisions when treatment choices become complicated.

Family Seeks Lessons Rather Than Blame

During the hearing, Holly Branson said her concerns were not about blaming individual doctors but about understanding what happened and preventing similar situations in the future.

Several doctors involved in Lady Joan’s treatment expressed regret and acknowledged that different decisions might have changed the outcome.

The coroner’s conclusion did not accuse any individual of wrongdoing but identified failures in care that contributed to Lady Joan’s death.

For the Branson family, the focus now is on ensuring that lessons are learned from the tragedy.

Remembering Joan Branson

Beyond the circumstances of her death, Lady Joan was remembered as a devoted wife, mother and grandmother.

While Sir Richard Branson became internationally known as the founder of the Virgin Group, Joan largely stayed away from the spotlight.

Those close to the family have described her as a compassionate and supportive presence throughout Branson’s life and career.

Her death has now prompted renewed discussion about hospital safety, medical decision-making and the importance of preventing avoidable blood clot complications.

The inquest’s findings provide some answers about what happened, but they also leave a lasting reminder of the importance of timely medical intervention when patients face serious clotting risks.